EVENTIDE ASSET MANAGEMENT, LLC Q3 2020 Filing
Filed November 13, 2020
Portfolio Value
$5.1B
Holdings
142
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (142 positions)
| Stock | Value |
|---|---|
ASNDASCENDIS PHARMA A/S | $263.9B |
EXASEXACT SCIENCES CORP | $177.4B |
WWAYFAIR INC | $167.7B |
TTDTHE TRADE DESK INC | $156.4B |
FIVNFIVE9 INC | $150.3B |
CRWDCROWDSTRIKE HLDGS INC | $136.6B |
SRPTSAREPTA THERAPEUTICS INC | $130.8B |
—BIOHAVEN PHARMACTL HLDG CO L | $116.0B |
IGVISHARES TR | $112.5B |
DTDYNATRACE INC | $108.5B |
ROPROPER TECHNOLOGIES INC | $100.0B |
TWLOTWILIO INC | $95.9B |
MTDMETTLER TOLEDO INTERNATIONAL | $87.9B |
LOWLOWES COS INC | $85.3B |
—MYOKARDIA INC | $84.7B |
POOLPOOL CORP | $83.6B |
WCNWASTE CONNECTIONS INC | $83.5B |
IDXXIDEXX LABS INC | $79.0B |
XIFRNEXTERA ENERGY PARTNERS LP | $76.5B |
FVRRFIVERR INTL LTD | $71.8B |
TTTRANE TECHNOLOGIES PLC | $71.5B |
KRTXKARUNA THERAPEUTICS INC | $69.7B |
HUBSHUBSPOT INC | $68.9B |
LRCXEURLAM RESEARCH CORP | $66.9B |
ODFLOLD DOMINION FREIGHT LINE IN | $64.5B |
ASMLASML HOLDING N V | $63.5B |
TREXTREX CO INC | $63.2B |
VRSKVERISK ANALYTICS INC | $61.8B |
PLRXPLIANT THERAPEUTICS INC | $61.7B |
DHID R HORTON INC | $54.4B |
ANNXANNEXON INC | $52.4B |
IPHIINPHI CORP | $51.0B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $50.5B |
MRTXEURMIRATI THERAPEUTICS INC | $50.0B |
APTVAPTIV PLC | $49.2B |
BEPBROOKFIELD RENEWABLE PARTNER | $46.6B |
ECLECOLAB INC | $46.0B |
TREURTRILLIUM THERAPEUTICS INC | $45.4B |
8CWCROWN CASTLE INTL CORP NEW | $45.2B |
GTMZOOMINFO TECHNOLOGIES INC | $44.9B |
CITCINTAS CORP | $44.3B |
RNGRINGCENTRAL INC | $43.8B |
2L9BLUEPRINT MEDICINES CORP | $42.8B |
—GW PHARMACEUTICALS PLC | $42.4B |
ARGXARGENX SE | $42.0B |
SPTSPROUT SOCIAL INC | $37.7B |
MGAMAGNA INTL INC | $36.3B |
—FREELINE THERAPEUTICS HLDGS | $35.6B |
PANWPALO ALTO NETWORKS INC | $35.6B |
RCKTROCKET PHARMACEUTICALS INC | $35.4B |
HASIHANNON ARMSTRONG SUST INFR C | $35.0B |
NBIXNEUROCRINE BIOSCIENCES INC | $34.6B |
DDOGDATADOG INC | $34.3B |
SPLKCHFSPLUNK INC | $34.1B |
—TURNING POINT THERAPEUTICS I | $33.5B |
IMVTIMMUNOVANT INC | $32.8B |
VCYTVERACYTE INC | $30.2B |
1GSNNOVANTA INC | $29.8B |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $29.5B |
ZNTLZENTALIS PHARMACEUTICALS INC | $28.8B |
ROLROLLINS INC | $26.3B |
LIILENNOX INTL INC | $25.9B |
KALAKALA PHARMACEUTICALS INC | $25.9B |
VMCVULCAN MATLS CO | $25.3B |
—AVROBIO INC | $24.8B |
CGNXCOGNEX CORP | $23.4B |
OKTAOKTA INC | $23.1B |
AWMSKYWORKS SOLUTIONS INC | $23.0B |
SMARGBPSMARTSHEET INC | $21.6B |
KALVKALVISTA PHARMACEUTICALS INC | $21.2B |
CRNXCRINETICS PHARMACEUTICALS IN | $21.1B |
AYATLANTICA SUSTAINABLE INFR P | $21.1B |
MDBMONGODB INC | $20.3B |
SGENEURSEATTLE GENETICS INC | $20.1B |
STROSUTRO BIOPHARMA INC | $20.0B |
MPWRMONOLITHIC PWR SYS INC | $19.8B |
ADCTADC THERAPEUTICS SA | $19.1B |
XPOXPO LOGISTICS INC | $18.6B |
ISRGINTUITIVE SURGICAL INC | $17.7B |
RGENREPLIGEN CORP | $17.6B |
NRIXNURIX THERAPEUTICS INC | $17.4B |
ETNBGBP89BIO INC | $17.3B |
REGNREGENERON PHARMACEUTICALS | $17.3B |
BEPCBROOKFIELD RENEWABLE CORP | $16.7B |
PHATPHATHOM PHARMACEUTICALS INC | $16.5B |
CCXIEURCHEMOCENTRYX INC | $16.3B |
JAMFJAMF HLDG CORP | $16.2B |
XLRNACCELERON PHARMA INC | $16.1B |
—MAGENTA THERAPEUTICS INC | $16.0B |
—EIDOS THERAPEUTICS INC | $16.0B |
EPIEURESSA PHARMA INC | $15.3B |
XENEXENON PHARMACEUTICALS INC | $14.1B |
LWLAMB WESTON HLDGS INC | $13.5B |
ALLKGUSDALLAKOS INC | $13.0B |
—CHIASMA INC | $12.9B |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $12.5B |
KURAKURA ONCOLOGY INC | $12.3B |
MCXMCCORMICK & CO INC | $12.2B |
XNCRXENCOR INC | $11.6B |
RLAYRELAY THERAPEUTICS INC | $10.6B |
Page 1 of 2Next